TIBBIYAH - Disclosures
Tibbiyah signs agreement to build dialysis services JV
Argaam 06/09/2023
Tibbiyah’s unit signs SAR 25.9 mln contract with NUPCO
Argaam 22/08/2023
Tibbiyah signs MoU with Al-Hammad Medical for potential acquisition
Argaam 20/07/2023
Tibbiyah’s unit receives 3 POs worth SAR 25.9 mln
Argaam 17/07/2023
Tibbiyah shareholders approve 10% cash dividend for 2022
Argaam 19/06/2023
Tibbiyah board proposes 10% cash dividend for 2022
Argaam 02/04/2023
Tibbiyah unit signs SAR 52.7 mln medical supplies contract with NUPCO
Argaam 08/01/2023
Tibbiyah registers GenaLive Medical as new JV firm with BGI Almanahil
Argaam 26/12/2022
Tibbiyah subsidiary signs SAR 31.1 mln supply contract with NUPCO
Argaam 22/12/2022
Tibbiyah’s subsidiary signs SAR 36.4 mln contract with NUPCO
Argaam 21/12/2022
Tibbiyah acquires 51% stake in Innovative Care for SAR 213.5 mln
Argaam 30/08/2022
Tibbiyah inks JV deal with BGI Almanahil to set up lab testing, bioinformation services firm
Argaam 27/07/2022
Tibbiyah receives preliminary decision against subsidiary on SAR 19.3 mln customs fees claim
Argaam 26/07/2022
Tibbiyah shareholders approve 30% cash dividend for 2021, buyback of 210,000 shares
Argaam 30/06/2022
Tibbiyah inks final agreement to acquire 51% of Innovative Care
Argaam 13/03/2022
Tibbiyah board recommends 30% cash dividend for 2021
Argaam 13/03/2022
Tibbiyah shares to start trading on Nomu tomorrow
Argaam 02/03/2022
Tibbiyah shares to debut on Nomu on March 3
Argaam 01/03/2022
Tibbiyah’s retail offering 12.63x oversubscribed
Argaam 23/02/2022
Retail investors begin subscription to Tibbiyah's 1 mln shares today
Argaam Special 15/02/2022
Tibbiyah sets offering price at SAR 82, IPO books 48.8x covered
Argaam 09/02/2022
Tibbiyah issues prospectus for offering 5 mln shares on Nomu
Argaam 13/01/2022